Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for thrombophilia: a laboratory perspective.

Ian Jennings1, Peter Cooper

  • 1UK NEQAS (Blood Coagulation), Rutledge Mews, 3 Southbourne Road, Sheffield, UK. ian@coageqa.org.uk

British Journal of Biomedical Science
|April 12, 2003
PubMed
Summary

Thrombophilia testing aids in diagnosing blood clot risks. This review covers key laboratory assays for inherited and acquired thrombophilia, crucial for managing venous thromboembolism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Body Composition Changes in Patients on GLP-1 Receptor Agonists Undergoing an Intensive Cardiac Rehabilitation Program.

European journal of preventive cardiology·2026
Same author

Multi-Centre Study by UK NEQAS Blood Coagulation: A Product Specific Calibrator Would Correct Assay Related Differences in Samples Containing Efanesoctocog Alfa for Multiple One Stage and Chromogenic FVIII Assay Methods.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

Updated Diagnosis of von Willebrand Disease: Global Access, Genomic Insights and Quality Assurance.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

Performance of Factor VIII Extended Half-Life Product Measurements in External Quality Assessment Programmes.

International journal of laboratory hematology·2026
Same author

Laboratory and Point of Care Monitoring of Vitamin K Antagonist Treatment.

Handbook of experimental pharmacology·2025
Same author

Assay of Efanesoctocog Alfa in 200 Centres: Data From Collaborative NEQAS BC (United Kingdom) and ECAT (Netherlands) Exercise Autumn 2024.

Haemophilia : the official journal of the World Federation of Hemophilia·2025

Area of Science:

  • Clinical Medicine
  • Hematology
  • Laboratory Diagnostics

Background:

  • Venous thrombosis affects 1 in 1000 individuals annually, with pulmonary embolism a significant cause of death.
  • Thrombophilia, a predisposition to blood clots, is found in 25-30% of thromboembolic disease patients, and can be inherited or acquired.
  • Accurate diagnosis of thrombophilia is essential for effective patient management and prevention of recurrent events.

Purpose of the Study:

  • To review current laboratory testing strategies for thrombophilia diagnosis.
  • To highlight important considerations for laboratories performing thrombophilia assays.
  • To provide guidance on interpreting results in the context of clinical guidelines.

Main Methods:

  • Review of recently published guidelines on thrombophilia testing.
  • Discussion of recommended assays including protein C, protein S, antithrombin, activated protein C resistance, and antiphospholipid antibodies.
  • Consideration of genetic tests like polymerase chain reaction for prothrombin G20201A and coagulation screening tests.

Main Results:

  • Guidelines recommend a comprehensive panel of tests for thrombophilia diagnosis.
  • Specific assays include functional and genetic tests for common thrombophilic states.
  • Laboratories must address pre-analytical, analytical, and post-analytical factors for accurate testing.

Conclusions:

  • Standardized and validated laboratory testing is critical for diagnosing thrombophilia.
  • Understanding the nuances of each assay is essential for reliable results.
  • Effective thrombophilia testing supports personalized risk assessment and treatment strategies.

Related Experiment Videos